https://www.forex-news.com/
Forex-News has been the world leading economy news website since 2005. It has been a joyful path full of changing variables in this changing world. During the last three years we have also covered some of the most important news regarding Bitcoin and other cryptocurrencies. Wherever the news are, we are there.
, Novartis Receives FDA Therapeutic Breakthrough Status for Ligelizumab – Green Share | 01/14/21, Forex-News, Forex-News
Bitcoin
$31,787.33
+214.02
Ethereum
$1,221.90
+17.5
Litecoin
$137.42
-2.72
DigitalCash
$103.66
+2.02
Monero
$136.64
+2.23
Nxt
$0.01
-0
Ethereum Classic
$7.42
-0.55
Dogecoin
$0.01
0

Novartis Receives FDA Therapeutic Breakthrough Status for Ligelizumab – Green Share | 01/14/21

4
, Novartis Receives FDA Therapeutic Breakthrough Status for Ligelizumab – Green Share | 01/14/21, Forex-News, Forex-News


, Novartis Receives FDA Therapeutic Breakthrough Status for Ligelizumab – Green Share | 01/14/21, Forex-News, Forex-News

Novartis achieved an important partial success with its product candidate ligelizumab (QGE031) in the USA.

The health authority FDA has given the drug for the treatment of hives (chronic spontaneous urticaria; CSU) the status of “therapy breakthrough”, as Novartis announced on Thursday.

The agent may be used in patients who suffer from urticaria, but respond only inadequately to H1 antihistamine therapy. According to Novartis, CSU is an unpredictable and serious skin disease. It is characterized by the development of itchy, painful wheals (hives), swelling (angioedema), or both, which last for at least 6 weeks and occur for no known cause.

(Display)Matching new Barrier Reverse Convertibles

The FDA grants breakthrough therapy status to therapies that target a serious or life-threatening disease and that have potentially significant improvement over existing therapies in one or more significant clinical endpoints.

For the Novartis share in Swiss trading it is currently 0.46 percent high to 83.48 francs.

Basel (awp)

.



, Novartis Receives FDA Therapeutic Breakthrough Status for Ligelizumab – Green Share | 01/14/21, Forex-News, Forex-News

Get real time updates directly on you device, subscribe now.

, Novartis Receives FDA Therapeutic Breakthrough Status for Ligelizumab – Green Share | 01/14/21, Forex-News, Forex-News

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More